{{Rsnum
|rsid=9344
|Gene=CCND1
|Chromosome=11
|position=69648142
|Orientation=plus
|GMAF=0.4206
|Gene_s=CCND1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 30.4 | 41.1 | 28.6
| HCB | 33.6 | 45.3 | 21.2
| JPT | 17.7 | 54.9 | 27.4
| YRI | 3.4 | 28.6 | 68.0
| ASW | 3.5 | 42.1 | 54.4
| CHB | 33.6 | 45.3 | 21.2
| CHD | 37.6 | 42.2 | 20.2
| GIH | 35.6 | 40.6 | 23.8
| LWK | 1.8 | 39.1 | 59.1
| MEX | 19.0 | 37.9 | 43.1
| MKK | 2.6 | 38.5 | 59.0
| TSI | 26.5 | 50.0 | 23.5
| HapMapRevision=28
}}
{{PMID Auto
|PMID=20680537
|Title=Distribution of CCND1 A870G Polymorphism in Patients with Advanced Uterine Cervical Carcinoma
}}

{{PMID Auto
|PMID=21268129
|Title=Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley-A high risk area
}}

{{PMID Auto
|PMID=21723269
|Title=Genetic profiling of GSTP1, DPYD, FCGR2A, FCGR3A and CCND1 genes in an Argentinian population
}}

{{PMID Auto
|PMID=21890746
|Title=Effects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) polymorphism on outcome of advanced-stage squamous cell carcinoma of the head and neck are treatment dependent
|OA=1
}}
{{PMID Auto
|PMID=14724163
|Title=Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases.
|OA=1
}}

{{PMID Auto
|PMID=16465622
|Title=Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.
|OA=1
}}

{{PMID Auto
|PMID=16783567
|Title=Cyclin D1 splice variant and risk for non-Hodgkin lymphoma.
}}

{{PMID Auto
|PMID=18174243
|Title=Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.
|OA=1
}}

{{PMID Auto
|PMID=18507837
|Title=Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort.
|OA=1
}}

{{PMID Auto
|PMID=18547414
|Title=Genotyping panel for assessing response to cancer chemotherapy.
|OA=1
}}

{{PMID Auto
|PMID=19124506
|Title=Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer.
|OA=1
}}

{{PMID Auto
|PMID=19183483
|Title=Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.
|OA=1
}}

{{PMID Auto
|PMID=19258477
|Title=Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=19287456
|Title=Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome.
|OA=1
}}

{{PMID Auto
|PMID=19336552
|Title=Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.
|OA=1
}}

{{PMID Auto
|PMID=19372140
|Title=EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis.
|OA=1
}}

{{PMID Auto
|PMID=19543528
|Title=Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer.
|OA=1
}}

{{PMID Auto
|PMID=19585495
|Title=Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach.
}}

{{PMID Auto
|PMID=19750108
|Title=Decreased PM10 exposure attenuates age-related lung function decline: genetic variants in p53, p21, and CCND1 modify this effect.
|OA=1
}}

{{PMID Auto
|PMID=19941161
|Title=Combined genetic effect of CDK7 and ESR1 polymorphisms on breast cancer.
}}

{{PMID Auto
|PMID=21161398
|Title=Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls.
}}

{{PMID Auto
|PMID=21273603
|Title=Significant association of cyclin D1 single nucleotide polymorphisms with oral cancer in taiwan.
}}

{{PMID Auto
|PMID=21594903
|Title=CCND1 rs9344 polymorphisms are associated with the genetic susceptibility to cervical cancer in Chinese population.
}}

{{PMID Auto
|PMID=21965784
|Title=Interaction of CCND1 genotype and smoking habit in Taiwan lung cancer patients.
}}

{{PMID Auto
|PMID=22399638
|Title=Association of cyclin D1 genotypes with nasopharyngeal carcinoma risk.
}}

{{PMID Auto
|PMID=23072573
|Title=Multiplex Allele-Specific Amplification from Whole Blood for Detecting Multiple Polymorphisms Simultaneously
|OA=1
}}
{{GET Evidence
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs9344
|overall_frequency_n=4139
|overall_frequency_d=10758
|overall_frequency=0.384737
|n_genomes=14
|n_genomes_annotated=0
|n_haplomes=16
|n_articles=0
|n_articles_annotated=0
|autoscore=0
|webscore=N
}}

{{PMID Auto
|PMID=23125009
|Title=Significance of cyclin D1 polymorphisms in patients with head and neck cancer.
}}

{{PMID Auto
|PMID=23311506
|Title=The association of a variant in the cell cycle control gene CCND1 and obesity on the development of asthma in the Swiss SAPALDIA study.
}}

{{PMID Auto
|PMID=23354566
|Title=Prognostic significance of cyclin D1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy.
}}

{{PMID Auto
|PMID=23567490
|Title=The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy.
}}

{{PMID Auto
|PMID=23625573
|Title=A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.
}}

{{on chip | 23andMe v3}}